Research and Innovation

18 June 2020

News of the day

Coronavirus: EU-funded project announces promising results for potential treatment

EU-funded project Exscalate4CoV has announced that an already registered generic drug used to treat osteoporosis, Raloxifene, could be an effective treatment for COVID-19 positive patients with mild or asymptomatic infection. The project is funded under Horizon 2020, the EU research and innovation programme. It is using an EU-backed supercomputing platform, one of the world’s most powerful, to check the potential impact of known molecules against the genomic structure of coronavirus.

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said:

		Today, we need science more than ever. Since January we have mobilised all our efforts to support R&I actors in their respective fields to find solutions and stop the virus. This is why we have provided Exscalate4CoV with €3 million to fund their research, and I welcome the promising results they have achieved in helping get society back on track.

Permalink

Main URL

See also

Coronavirus research and innovation

Research infrastructures

EU reaffirms support for ESS research infrastructure

The EIB has signed an increase of EUR 50 million (SEK 520 million) in the existing credit facility with the European Spallation Source (ESS) in Lund, Sweden. The loan was extended under the “InnovFin – EU Finance for Innovators” programme, with the financial backing of the European Union under Horizon 2020, the EU’s programme for research and innovation. On the same occasion, the parties also agreed to extend the tenor of the existing EUR 100 million credit facility, aligning it with the planned end of the construction phase of the project.

Commissioner Gabriel said:

		Big science facilities such as ESS push boundaries of human knowledge and improve people’s lives with advances in many fields, from health to building materials. That is why we have supported ESS since the beginning through grants and loans funded by Horizon 2020, the EU’s research and innovation programme. This second loan under the InnovFin instrument brings ESS one step closer to reality.

Permalink

Main URL